Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 61

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 61
---
 a number of recent initial public
offerings, especially among companies with relatively smaller public floats. As a relatively small-capitalization company, we may experience
greater stock price volatility, extreme price run-ups, lower trading volume and less liquidity than large-capitalization companies. In
particular, our Common Stock may be subject to rapid and substantial price volatility, low volumes of trades and large spreads in bid
and ask prices. Such volatility, including any stock-run up, may be unrelated to our actual or expected operating performance, financial
condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our Common Stock.

In addition, if the trading volumes of our Common
Stock are low, persons buying or selling in relatively small quantities may easily influence prices of our Common Stock. This low volume
of trades could also cause the price of our Common Stock to fluctuate greatly, with large percentage changes in price occurring in any
trading day session.

| 36 |

Holders of our Common Stock may also not be able to
readily liquidate their investment or may be forced to sell at depressed prices due to low volume trading. Broad market fluctuations and
general economic and political conditions may also adversely affect the market price of our Common Stock. As a result of this volatility,
investors may experience losses on their investment in our Common Stock. A decline in the market price of our Common Stock also could
adversely affect our ability to issue additional Common Stock or other securities and our ability to obtain additional financing in the
future. No assurance can be given that an active market in our Common Stock will develop or be sustained. If an active market does not
develop, holders of our Common Stock may be unable to readily sell the shares they hold or may not be able to sell their shares at all.

<div align='center'>USE OF PROCEEDS</div>

We estimate that we will receive net proceeds from
the IPO of approximately $10,999,50012,120,000, after deducting underwriting discounts and commissions and estimated
offering expenses payable by us.

We plan to use the net proceeds of the IPO in the
following order of priority:

| ● | 20% of the net proceeds for merger and acquisition;                               |
| ● | 50% of the net proceeds for expansion of market; and                              |
| ● | 30% of the net proceeds for working capital and other general corporate purposes. |

To the extent that our actual net proceeds is not
sufficient